247 related articles for article (PubMed ID: 16808996)
1. Phosphodiesterase 3 and 5 and cyclic nucleotide-gated ion channel expression in rat trigeminovascular system.
Kruse LS; Sandholdt NT; Gammeltoft S; Olesen J; Kruuse C
Neurosci Lett; 2006 Aug; 404(1-2):202-7. PubMed ID: 16808996
[TBL] [Abstract][Full Text] [Related]
2. PDE9A, PDE10A, and PDE11A expression in rat trigeminovascular pain signalling system.
Kruse LS; Møller M; Tibaek M; Gammeltoft S; Olesen J; Kruuse C
Brain Res; 2009 Jul; 1281():25-34. PubMed ID: 19445908
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide-induced changes in endothelial expression of phosphodiesterases 2, 3, and 5.
Schankin CJ; Kruse LS; Reinisch VM; Jungmann S; Kristensen JC; Grau S; Ferrari U; Sinicina I; Goldbrunner R; Straube A; Kruuse C
Headache; 2010 Mar; 50(3):431-41. PubMed ID: 19751368
[TBL] [Abstract][Full Text] [Related]
4. Expression of cyclic GMP-inhibited phosphodiesterases 3A and 3B (PDE3A and PDE3B) in rat tissues: differential subcellular localization and regulated expression by cyclic AMP.
Liu H; Maurice DH
Br J Pharmacol; 1998 Dec; 125(7):1501-10. PubMed ID: 9884079
[TBL] [Abstract][Full Text] [Related]
5. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
de Vente J; Markerink-van Ittersum M; Vles JS
J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
Murray F; MacLean MR; Pyne NJ
Br J Pharmacol; 2002 Dec; 137(8):1187-94. PubMed ID: 12466227
[TBL] [Abstract][Full Text] [Related]
7. Widespread expression of olfactory cyclic nucleotide-gated channel genes in rat brain: implications for neuronal signalling.
Kingston PA; Zufall F; Barnstable CJ
Synapse; 1999 Apr; 32(1):1-12. PubMed ID: 10188632
[TBL] [Abstract][Full Text] [Related]
8. Real-time monitoring of phosphodiesterase inhibition in intact cells.
Herget S; Lohse MJ; Nikolaev VO
Cell Signal; 2008 Aug; 20(8):1423-31. PubMed ID: 18467075
[TBL] [Abstract][Full Text] [Related]
9. Cyclic nucleotide PDE-3. Quantitation of PDE-3A and -3B mRNAs in rat tissues by RNase protection assay.
Nagaoka T; Shirakawa T; Kasuya J; Balon TW; Manganiello VC; Fujita-Yamaguchi Y
Cell Biochem Biophys; 1998; 29(1-2):49-66. PubMed ID: 9631238
[TBL] [Abstract][Full Text] [Related]
10. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis.
Netherton SJ; Maurice DH
Mol Pharmacol; 2005 Jan; 67(1):263-72. PubMed ID: 15475573
[TBL] [Abstract][Full Text] [Related]
12. Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: immunohistochemical and molecular biology study.
Oelke M; Hedlund P; Albrecht K; Ellinghaus P; Stief CG; Jonas U; Andersson KE; Uckert S
Urology; 2006 May; 67(5):1111-6. PubMed ID: 16635522
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological and molecular comparison of K(ATP) channels in rat basilar and middle cerebral arteries.
Ploug KB; Edvinsson L; Olesen J; Jansen-Olesen I
Eur J Pharmacol; 2006 Dec; 553(1-3):254-62. PubMed ID: 17101127
[TBL] [Abstract][Full Text] [Related]
14. Expression of cyclic nucleotide phosphodiesterase 3A in isolated rat submandibular acini.
Shimizu K; Murata T; Hiramoto K; Sugiyama T; Nakagawa T; Manganiello VC; Tagawa T
Arch Oral Biol; 2006 Feb; 51(2):83-8. PubMed ID: 16102722
[TBL] [Abstract][Full Text] [Related]
15. Characterization of 3',5' cyclic nucleotide phosphodiesterase activity in Y79 retinoblastoma cells: absence of functional PDE6.
White JB; Thompson WJ; Pittler SJ
Mol Vis; 2004 Oct; 10():738-49. PubMed ID: 15480303
[TBL] [Abstract][Full Text] [Related]
16. New insight into the role of phosphodiesterase 3A in porcine oocyte maturation.
Sasseville M; Côté N; Guillemette C; Richard FJ
BMC Dev Biol; 2006 Oct; 6():47. PubMed ID: 17038172
[TBL] [Abstract][Full Text] [Related]
17. Partial characterization of the active site human platelet cAMP phosphodiesterase, PDE3A, by site-directed mutagenesis.
Cheung PP; Yu L; Zhang H; Colman RW
Arch Biochem Biophys; 1998 Dec; 360(1):99-104. PubMed ID: 9826434
[TBL] [Abstract][Full Text] [Related]
18. Selective blockade of phosphodiesterase types 2, 5 and 9 results in cyclic 3'5' guanosine monophosphate accumulation in retinal pigment epithelium cells.
Diederen RM; La Heij EC; Markerink-van Ittersum M; Kijlstra A; Hendrikse F; de Vente J
Br J Ophthalmol; 2007 Mar; 91(3):379-84. PubMed ID: 16943225
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of endothelial cell permeability by cGMP via phosphodiesterases 2 and 3.
Surapisitchat J; Jeon KI; Yan C; Beavo JA
Circ Res; 2007 Oct; 101(8):811-8. PubMed ID: 17704206
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
